Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The 14;18 translocation is generally considered a good marker for follicular lymphomas and it has also been suggested that it is of prognostic significance in this disease. It has also been claimed that the bcl-2 protein can be detected by immunohistology only in lymphoma carrying t(14;18). We have raised antibodies to the bcl-2 protein and shown that expression of the protein is not specific for the translocation and have also demonstrated that there is no correlation between prognosis and the presence of the translocation. It is also evident that t(14;18) is present only in about two-thirds of follicular lymphoma patients (and is found in 20-30% of diffuse lymphomas).


Journal article


Nouv Rev Fr Hematol

Publication Date





397 - 399


Biomarkers, Tumor, Chromosomes, Human, Pair 14, Chromosomes, Human, Pair 18, Gene Expression Regulation, Neoplastic, Humans, Leukemia, Lymphoma, Lymphoma, Follicular, Neoplasm Proteins, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Translocation, Genetic